CD34 expression in the young group (7.48±0.85) was approximately 35% higher than in the >60 years of age non-AMD group (7.05±0.88); however, this difference did not reach statistical significance (p = 0.095). This evidence concerns the gene CD34 and age-related macular degeneration.